These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 7701913

  • 1. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
    Diekmann L, Beelen DW, Quabeck K, Becher R, Schulte Holthausen H, Bützler R, Schaefer UW, Opalka B.
    Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
    Delage R, Soiffer RJ, Dear K, Ritz J.
    Blood; 1991 Nov 15; 78(10):2759-67. PubMed ID: 1824268
    [Abstract] [Full Text] [Related]

  • 3. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 4. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR.
    Haematologica; 1996 Mar 15; 81(3):201-7. PubMed ID: 8767524
    [Abstract] [Full Text] [Related]

  • 5. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 15; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

  • 7. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S, Galili N, Sklar JL, Donlon TA, Blume KG, Cleary ML.
    Leukemia; 1990 Aug 01; 4(8):541-7. PubMed ID: 2201832
    [Abstract] [Full Text] [Related]

  • 8. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A, Lion T, Kalhs P, Mitterbauer G, Henn T, Haas O, Födinger M, Kier P, Forstinger C, Quehenberger P.
    Leukemia; 1993 Nov 01; 7(11):1766-72. PubMed ID: 8231244
    [Abstract] [Full Text] [Related]

  • 9. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Alyea EP, Soiffer RJ, Roy DC, Ritz J.
    Blood; 1994 Oct 01; 84(7):2109-14. PubMed ID: 7919323
    [Abstract] [Full Text] [Related]

  • 10. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H.
    Leukemia; 1995 Aug 01; 9(8):1353-60. PubMed ID: 7643624
    [Abstract] [Full Text] [Related]

  • 11. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM, Schattenberg A, Mensink EJ, Geurts Van Kessel A, Smetsers TF, Knops GH, Linders EH, De Witte T.
    J Clin Oncol; 1993 Mar 01; 11(3):513-9. PubMed ID: 8445426
    [Abstract] [Full Text] [Related]

  • 12. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
    Arnold R, Janssen JW, Heinze B, Bunjes D, Hertenstein B, Wiesneth M, Kubanek B, Heimpel H, Bartram CR.
    Leukemia; 1993 May 01; 7(5):747-51. PubMed ID: 8483329
    [Abstract] [Full Text] [Related]

  • 13. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB, Tavares Rde C, Hassan R, Zalcberg I, Tabak DG, Seuánez HN.
    Leuk Res; 2002 Feb 01; 26(2):129-41. PubMed ID: 11755463
    [Abstract] [Full Text] [Related]

  • 14. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.
    Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P.
    Blood; 1995 May 01; 85(9):2632-8. PubMed ID: 7727789
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1147-52. PubMed ID: 8971386
    [Abstract] [Full Text] [Related]

  • 16. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 18. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Román J, Martín C, Torres A, García A, Andrés P, García MJ, Baiget M.
    Leuk Lymphoma; 1998 Feb 15; 28(5-6):541-50. PubMed ID: 9613984
    [Abstract] [Full Text] [Related]

  • 19. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J, Serrano J, Jiménez A, Castillejo JA, Reina ML, González MG, Rodríguez MC, García I, Sánchez J, Maldonado J, Torres A.
    Haematologica; 2000 Feb 15; 85(2):173-80. PubMed ID: 10681725
    [Abstract] [Full Text] [Related]

  • 20. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.
    Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y.
    Blood; 1993 Feb 15; 81(4):1089-93. PubMed ID: 8427990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.